- Home
- YSXT vs CRVO Comparison
YSXT vs CRVO Comparison
Compare YSXT & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YSXT
- CRVO
- Stock Information
- Founded
- YSXT 2011
- CRVO 2001
- Country
- YSXT China
- CRVO United States
- Employees
- YSXT N/A
- CRVO N/A
- Industry
- YSXT Automotive Aftermarket
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- YSXT Consumer Discretionary
- CRVO Health Care
- Exchange
- YSXT Nasdaq
- CRVO Nasdaq
- Market Cap
- YSXT 58.6M
- CRVO 67.4M
- IPO Year
- YSXT 2024
- CRVO N/A
- Fundamental
- Price
- YSXT $2.49
- CRVO $8.50
- Analyst Decision
- YSXT
- CRVO Strong Buy
- Analyst Count
- YSXT 0
- CRVO 6
- Target Price
- YSXT N/A
- CRVO $19.17
- AVG Volume (30 Days)
- YSXT 713.3K
- CRVO 92.4K
- Earning Date
- YSXT 07-31-2025
- CRVO 11-11-2025
- Dividend Yield
- YSXT N/A
- CRVO N/A
- EPS Growth
- YSXT N/A
- CRVO N/A
- EPS
- YSXT 0.18
- CRVO N/A
- Revenue
- YSXT $71,452,736.00
- CRVO $7,776,968.00
- Revenue This Year
- YSXT N/A
- CRVO N/A
- Revenue Next Year
- YSXT N/A
- CRVO N/A
- P/E Ratio
- YSXT $13.37
- CRVO N/A
- Revenue Growth
- YSXT 22.04
- CRVO N/A
- 52 Week Low
- YSXT $1.68
- CRVO $1.80
- 52 Week High
- YSXT $9.96
- CRVO $16.94
- Technical
- Relative Strength Index (RSI)
- YSXT 43.82
- CRVO 51.94
- Support Level
- YSXT $2.52
- CRVO $7.90
- Resistance Level
- YSXT $2.60
- CRVO $8.93
- Average True Range (ATR)
- YSXT 0.29
- CRVO 0.42
- MACD
- YSXT -0.02
- CRVO 0.06
- Stochastic Oscillator
- YSXT 15.98
- CRVO 84.30
About YSXT YSX Tech. Co. Ltd Class A Ordinary Shares
YSX Tech Co Ltd provide business solutions to enterprise customers, mainly insurance companies and brokerages, in China. The company has three operating segments: Auto Insurance Aftermarket Value-added Services, Other Scenario-based Customized Services and Software Development and Information Technology Services. Key revenue is generated from Auto Insurance Aftermarket Value-added Services segment which include four types value added services: vehicle safety inspection and check services, vehicle driving risk screening services, designated driver and rescue services and vehicle maintenance and other value-added services.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.